Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Urakami

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
BJU International|April 3, 2009
Five-year longitudinal effect of radical perineal prostatectomy on health-related quality of life in Japanese men, using general and disease-specific measuresShogo Inoue, Hiroaki Shiina, Takeo Hiraoka, et al.
International Journal of Clinical Oncology|September 12, 2012
Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinomaYosuke Yasuda, Yasuhisa Fujii, Takeshi Yuasa, et al.
Urology|January 28, 2015
Patient-perceived satisfaction after definitive treatment for men with high-risk prostate cancer: radical prostatectomy vs. intensity-modulated radiotherapy with androgen deprivation therapyShinya Yamamoto, Hitoshi Masuda, Shinji Urakami, et al.
International Journal of Cancer|April 24, 2008
Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cellsNobuyuki Kikuno, Hiroaki Shiina, Shinji Urakami, et al.
Urologia Internationalis|November 14, 2012
Evaluation of the RENAL nephrometry scoring system in adopting nephron-sparing surgery for cT1 renal cancerYosuke Yasuda, Takeshi Yuasa, Shinya Yamamoto, et al.
Cancer Diagnosis & Prognosis|July 5, 2023
A Case Report of Aggressive Fumarate Hydrase-deficient Renal Cell Carcinoma With Loss of HLA AntigensYuji Miura, Takanobu Motoshima, Toshiki Anami, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 23, 2017
Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screeningShinji Urakami, Naoko Inoshita, Suguru Oka, et al.
International Urology and Nephrology|December 20, 2007
Long-term control or possible cure? Treatment of stage D2 prostate cancer under chemotherapy using cisplatin and estramustine phosphate followed by maximal androgen blockadeShinji Urakami, Hiroaki Shiina, Masahiro Sumura, et al.
International Journal of Clinical Oncology|August 14, 2012
Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitorsYosuke Yasuda, Kazutaka Saito, Takeshi Yuasa, et al.
Clinical Genitourinary Cancer|May 15, 2017
Effect of Lymphadenectomy During Radical Nephroureterectomy in Locally Advanced Upper Tract Urothelial CarcinomaMasaomi Ikeda, Kazumasa Matsumoto, Kazushige Sakaguchi, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
BJU International|April 3, 2009
Five-year longitudinal effect of radical perineal prostatectomy on health-related quality of life in Japanese men, using general and disease-specific measuresShogo Inoue, Hiroaki Shiina, Takeo Hiraoka, et al.
International Journal of Clinical Oncology|September 12, 2012
Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinomaYosuke Yasuda, Yasuhisa Fujii, Takeshi Yuasa, et al.
Urology|January 28, 2015
Patient-perceived satisfaction after definitive treatment for men with high-risk prostate cancer: radical prostatectomy vs. intensity-modulated radiotherapy with androgen deprivation therapyShinya Yamamoto, Hitoshi Masuda, Shinji Urakami, et al.
International Journal of Cancer|April 24, 2008
Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cellsNobuyuki Kikuno, Hiroaki Shiina, Shinji Urakami, et al.
Urologia Internationalis|November 14, 2012
Evaluation of the RENAL nephrometry scoring system in adopting nephron-sparing surgery for cT1 renal cancerYosuke Yasuda, Takeshi Yuasa, Shinya Yamamoto, et al.
Cancer Diagnosis & Prognosis|July 5, 2023
A Case Report of Aggressive Fumarate Hydrase-deficient Renal Cell Carcinoma With Loss of HLA AntigensYuji Miura, Takanobu Motoshima, Toshiki Anami, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 23, 2017
Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screeningShinji Urakami, Naoko Inoshita, Suguru Oka, et al.
International Urology and Nephrology|December 20, 2007
Long-term control or possible cure? Treatment of stage D2 prostate cancer under chemotherapy using cisplatin and estramustine phosphate followed by maximal androgen blockadeShinji Urakami, Hiroaki Shiina, Masahiro Sumura, et al.
International Journal of Clinical Oncology|August 14, 2012
Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitorsYosuke Yasuda, Kazutaka Saito, Takeshi Yuasa, et al.
Clinical Genitourinary Cancer|May 15, 2017
Effect of Lymphadenectomy During Radical Nephroureterectomy in Locally Advanced Upper Tract Urothelial CarcinomaMasaomi Ikeda, Kazumasa Matsumoto, Kazushige Sakaguchi, et al.
Pageof 14